These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8501596)

  • 21. In vitro development of third- and fourth-stage larvae of Dirofilaria immitis: comparison of basal culture media, serum levels and possible serum substitutes.
    Lok JB; Mika-Grieve M; Grieve RB; Chin TK
    Acta Trop; 1984 Jun; 41(2):145-54. PubMed ID: 6147986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetracycline inhibits development of the infective-stage larvae of filarial nematodes in vitro.
    Smith HL; Rajan TV
    Exp Parasitol; 2000 Aug; 95(4):265-70. PubMed ID: 11038309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dipetalonema viteae (Filarioidea): development of the infective larvae in vitro.
    Tanner M
    Acta Trop; 1981 Sep; 38(3):241-9. PubMed ID: 6118032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parasitological observations on Meriones unguiculatus singly or multiply infected with Brugia pahangi.
    Denham DA; Suswillo RR; Chusattayanond W
    Parasitology; 1984 Apr; 88 ( Pt 2)():295-301. PubMed ID: 6718056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory responses to migrating Brugia pahangi third-stage larvae.
    Porthouse KH; Chirgwin SR; Coleman SU; Taylor HW; Klei TR
    Infect Immun; 2006 Apr; 74(4):2366-72. PubMed ID: 16552066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoregulation in experimental filariasis. II. Responses to parasite and nonparasite antigens in jirds with Brugia pahangi.
    Lammie PJ; Katz SP
    J Immunol; 1983 Mar; 130(3):1386-9. PubMed ID: 6337217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and migration of infective Brugia pahangi larvae administered orally to neonatal jirds.
    Bosworth W; Chernin E
    J Parasitol; 1976 Aug; 62(4):654-5. PubMed ID: 957049
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination of Jirds, Meriones unguiculatus, against Litomosoides carinii and Brugia pahangi using irradiate larvae of L. carinii.
    Storey DM; Al-Mukhtar AS
    Tropenmed Parasitol; 1982 Mar; 33(1):23-4. PubMed ID: 7101438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that sulfisoxazole, an antibacterial sulfonamide, can adversely affect the development of Brugia pahangi in Aedes aegypti mosquitoes.
    Jaffe JJ; Doremus HM; Meymarian E; Chrin LR
    J Parasitol; 1978 Apr; 64(2):193-7. PubMed ID: 641660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moulting and exsheathment of the infective larvae of Onchocerca lienalis (Filarioidea) in vitro.
    Pudney M; Litchfield T; Bianco AE; Mackenzie CD
    Acta Trop; 1988 Mar; 45(1):67-76. PubMed ID: 2896448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laboratory transmission of lymphatic filariasis by vector mosquitoes.
    Ewert A; Wu CC; Fan PC
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):73-8. PubMed ID: 3660071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro culture of equine strongylidae to the fourth larval stage in a cell-free medium.
    Chapman MR; Hutchinson GW; Cenac MJ; Klei TR
    J Parasitol; 1994 Apr; 80(2):225-31. PubMed ID: 8158465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The observation of microfilarial rate and density in cats inoculated with increasing numbers of Brugia pahangi infective larvae.
    Junhom W; Chungpivat S; Viseshakul N
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():40-2. PubMed ID: 17547050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies with Brugia pahangi 10. An attempt to demonstrate the sharing of antigenic determinants between the worm and its hosts.
    McGreevy PB; Ismail MM; Phillips TM; Denham DA
    J Helminthol; 1975 Jun; 49(2):107-13. PubMed ID: 50339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A diffusion chamber technique for detecting compounds with clinical prophylactic activity against Brugia pahangi.
    Court JP
    Tropenmed Parasitol; 1982 Jun; 33(2):83-6. PubMed ID: 7112685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of gamma radiation on Brugia malayi infective larvae and their intracellular Wolbachia bacteria.
    Rao R; Moussa H; Vanderwaal RP; Sampson E; Atkinson LJ; Weil GJ
    Parasitol Res; 2005 Oct; 97(3):219-27. PubMed ID: 15997407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of host sex on the L3 to L4 molt of Brugia malayi.
    Ganley-Leal LM
    J Parasitol; 2005 Oct; 91(5):1222-5. PubMed ID: 16419774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temperature is a cue for gene expression in the post-infective L3 of the parasitic nematode Brugia pahangi.
    Hunter SJ; Thompson FJ; Tetley L; Devaney E
    Mol Biochem Parasitol; 2001 Jan; 112(1):1-9. PubMed ID: 11166381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ivermectin inhibits molting of Wuchereria bancrofti third stage larvae in vitro.
    Baird JK; Riberu W; Masbar S; Purnomo
    J Parasitol; 1991 Feb; 77(1):162-3. PubMed ID: 1992087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brugia pahangi: in vivo tissue migration of early L3 alters gene expression.
    Chirgwin SR; Coleman SU; Klei TR
    Exp Parasitol; 2008 Jan; 118(1):89-95. PubMed ID: 17706647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.